AzTrials
AzTrials

PTSDNCT06123065

Feasibility and Efficacy of A Yoga Intervention for Comorbid Chronic Pain and PTSD

A study testing Yoga in people with PTSD and Chronic Pain, run by Hunter Holmes Mcguire Veteran Affairs Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot quasi-randomized study is test the feasibility, acceptability, and initial efficacy of Yoga for Warriors treatment program for comorbid chronic pain and PTSD, conducted virtually through the Richmond Veterans Affairs Medical Center (RICVAMC). the main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
PTSD, Chronic Pain
What is being tested?
Yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
1 siteUnited States
Study dates
1 Apr 2021to 30 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of chronic pain (defined as pain for > 3 months) in the electronic medical record and a score of 50 or more on the Pain Disability Questionnaire (PDQ)
  • Probable PTSD defined as being above the clinical threshold on the PTSD Checklist for DSM-5 (PCL-5), sum score at or above 25
  • Able to stand up from sitting on the floor without assistance
  • Able to ambulate community distances without an assistive device
  • Intact sensation in lower extremities below knees
  • Medical clearance by primary care provider
  • Access to a computer/laptop/ipad with internet and video capability.

Who cannot join

  • Fall risk
  • Pregnancy
  • Joint replacement within the past 12 months
  • Active alcohol/other substance abuse or dependence (unless actively engaged in treatment)
  • Current psychotic disorder or hospitalization with psychotic symptoms in past 3 months
  • Active (past 3 months) suicidal or homicidal ideation.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Richmond Veterans Affairs Medical Center

    Richmond, Virginia, 23249

Other trials in United States

About this study

Official title: Yoga for Warriors: A Pilot Study of Feasibility and Efficacy of A Yoga Intervention for Veterans With Comorbid Chronic Pain and PTSD

The goal of this pilot quasi-randomized study is test the feasibility, acceptability, and initial efficacy of Yoga for Warriors treatment program for comorbid chronic pain and PTSD, conducted virtually through the Richmond Veterans Affairs Medical Center (RICVAMC).

the main questions it aims to answer are:

  1. Whether a virtual intervention for chronic pain and PTSD is feasible and acceptable for veterans.
  2. Using a wait-list control group design, to determine preliminary efficacy of the intervention.
  3. Examine follow-up data to determine if benefits are maintained over time.
Read the detailed description

The study will be a pilot quasi-randomized controlled design comparing the 8-session Yoga for Warriors program, conducted via a web-based platform, utilizing a wait-list control, with wait-list participants being enrolled in subsequent groups. Measures of treatment satisfaction will be given and rates of initiation following screening and drop-out will be measured. A battery of assessments will be given at baseline (group introduction), at mid-point (around session 4), and following completion of the group. To determine maintenance effects, select assessments and re-administration of the study assessment battery will be conducted 3 months post-completion.

Potentially interested participants will be screened for eligibility. Screening for eligibility will occur over the phone and those who are interested in participating and willing to engage in the online format and who meet inclusion criteria based on study staff screening will go through the informed consent process over the phone or virtually. Collection of informed consent from participants will not include written documentation of informed consent given the fully virtual nature of this study during the coronavirus pandemic (COVID-19) restrictions (waiver of documentation of consent has been submitted). Paperless recording of willingness to participate will take place, with no written documentation of consent to participate. Participants will attend an initial online orientation session (prior to the first yoga session), either in a group format or individually, where they will be provided information on the group, will be randomized into the treatment group or to the wait-list control group. To attend the orientation session and all yoga sessions, participants will be emailed the specific, secured link to the online platform. Participants will complete the measures over the phone with the study coordinator. This will be an 8 week (+1 orientation session) group conducted remotely, online, with additional self-report measures completed mid-treatment, post-treatment, and at follow-up, in the same manner as described above.

Conditions
PTSD, Chronic Pain
Being tested
Yoga
Keywords
Yoga, Virtual Intervention
Medical subject headings
Stress Disorders, Post-Traumatic, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • YogaBehavioural

    Also called Complementary and Alternative Intervention

    8 week Yoga for chronic pain and PTSD group intervention, conducted virtually

Study groups in NCT06123065
Study groupRoleWhat they receive
ActiveExperimentalImmediately enrolled into Yoga intervention. Completed orientation and baseline measures then began 8-week yoga group intervention.
Receives: Behavioral: Yoga
WaitlistOtherDelayed Intervention. Waitlist individuals attended orientation and completed baseline measures. After completion of re-assessment of measures 8 weeks later, then enrolled into Active arm.
Receives: Behavioral: Yoga

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD Checklist for Diagnostic and Statistic Manual for Mental Disorders 5 (DSM-5)

    Assess current symptoms of PTSD in line with DSM-5 criteria (20 items)

    Measured: past week; assessed at baseline, mid-treatment (after week 4), post-treatment (after week 8), 3 month follow up

  2. Pain Disability Questionnaire

    Assesses self report of impact of pain in functioning (15 items)

    Measured: past week; assessed at baseline, mid-treatment (after week 4), post-treatment (after week 8), 3 month follow up; Items rated on 1 to 10-point scale; higher scores indicate worse outcome

  3. Pain Catastrophizing Scale

    Assesses self report of thoughts and worries related to chronic pain (13 items)

    Measured: current; past week; assessed at baseline, mid-treatment (after week 4), post-treatment (after week 8), 3 month follow up; Items rated 0 to 4; higher scores indicate worse outcomes

Secondary outcomes (7)
  1. Client Satisfaction Questionnaire-8 (CSQ-8)

    Th CSQ is an 8-item measure assesses general intervention satisfaction

    Measured: Time in intervention; Assessed at post-treatment (8 weeks); Items rated 1 to 4; higher scores indicate better outcomes

  2. Patient Health Questionnaire-9 (PHQ-9)

    The PHQ-9 assesses depression severity

    Measured: Past 2 weeks; assessed at baseline and post-treatment (8 weeks); Items rated 0 to 3; higher scores indicate worse outcomes

  3. Generalized Anxiety Disorder 7-Item Scale (GAD-7)

    The GAD-7 measures anxiety experienced

    Measured: Past 2 weeks; assessed at baseline and post-treatment (8 weeks); Items rated 0 to 3; higher scores indicate worse outcomes

  4. Patient Reported Outcome Measurement Information System (PROMIS) Short Form Anger

    Assesses emotional distress and anger (5 items)

    Measured: Past 7 days; assessed at baseline and post-treatment (8 weeks); Items rated 1 to 5; raw scores converted to T scores; higher scores mean worse outcomes

  5. Patient Reported Outcome Measurement Information System (PROMIS) Short Form Social Roles

    Assesses ability to participate in social roles and activities

    Measured: Past 7 days; assessed at baseline and post-treatment; (8 weeks); Items rated 1 to 5; raw scores converted to T scores; higher scores mean better outcomes

  6. Tampa Scale for Kinesiophobia (TSK-11)

    The TSK-11 is an 11-item scale used to measure general perceptions of pain interference

    Measured: Current; assessed at baseline, mid-treatment (4 weeks), post-treatment (8 weeks), 3 month follow up; Items rated 1 to 4; higher scores indicate worse outcomes

  7. Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (LES-Q-SF)

    The Q-LES-Q-SF is a 16-item scale used to measure quality of life

    Measured: past week; assessed at baseline, post-treatment (8 weeks), 3 month follow up; Items rated 1 to 5; higher scores indicate better outcomes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2023
  2. Study start1 Apr 2021
  3. Primary completion30 Aug 2022
  4. Study completion30 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Crossover
Model description
Delayed cross-over design, with a Waitlist control. This study was a quasi-randomization to Active or Waitlist and Waitlist individuals were then moved to the Active group after assessment.
Masking
None (open label)
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06123065
Sponsor's protocol ID
1572859
Status last verified
Nov 2023
First submitted
30 Oct 2023
Last updated
8 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Fully de-identified participant level data and aggregate data (all collected IPD) will be made available to qualified researchers who contact the Study PI per the Institutional Review Board's approved data management and sharing plan.

Publications

  • Chopin SM, Sheerin CM, Meyer BL. Yoga for warriors: An intervention for veterans with comorbid chronic pain and PTSD. Psychol Trauma. 2020 Nov;12(8):888-896. doi: 10.1037/tra0000649. Epub 2020 Jul 23.

    PubMed 32700935
  • Chopin SM, Zaur AJ, Fountain C, Claros Nunez A, Sheerin CM. Feasibility of a Virtual Adaptation of a Yoga Intervention for Veterans with Chronic Pain and Posttraumatic Stress Disorder. J Integr Complement Med. 2025 Jan;31(1):92-99. doi: 10.1089/jicm.2024.0512. Epub 2024 Sep 10.

    PubMed 39253832

Questions about this trial

What is this clinical trial studying?

A study testing Yoga in people with PTSD and Chronic Pain, run by Hunter Holmes Mcguire Veteran Affairs Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD Checklist for Diagnostic and Statistic Manual for Mental Disorders 5 (DSM-5) (time frame: past week; assessed at baseline, mid-treatment (after week 4), post-treatment (after week 8), 3 month follow up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06123065, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in